Assignee
PLEX PHARMACEUTICALS INC
US·2 granted patents·4 pending applications·0 citations·filing 2018–2022
Top patents by PatentIndex Score
6 records- 0160US12371406B2Dual acting FKBP12 and FKBP52 inhibitorsPLEX PHARMACEUTICALS INC·Filed 2021·Granted Jul 29, 2025·0 cites·33 claims
- 0255US2024327439A1Pharmacological agents for preventing and treating cataracts and presbyopia eye diseasesPLEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0354US2025019352A1Pharmacological agents for treating ophthalmic diseasesPLEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0450US12065407B2Dual acting FKBP12 and FKBP52 inhibitorsPLEX PHARMACEUTICALS INC·Filed 2018·Granted Aug 20, 2024·0 cites·9 claims
- 0549US2024000812A1Pharmacological agents for treating conditions of the eyePLEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0641US2022241247A1Pharmacological agents for treating protein aggregation diseases of the eyePLEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PLEX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →